http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101874798-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
filingDate 2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c668b1c9ea7d09cb184ee46d80e18f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4168d075f43bfe5d199c09aaf74482c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_403454d199643a41762e82c894c42c56
publicationDate 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101874798-B
titleOfInvention Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
abstract The invention relates to a difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase, which is shown as the formula (I), a pharmaceutical compound containing the inhibitor as well as the application thereof in preparing medicaments for treating and preventing state of illness of a subject, which is induced by leukotriene A4 hydrolase and cyclooxygenase, the application in preparing medicaments for treating, preventing or inhibiting inflammation of the subject, and the application in preparing medicaments for inhibiting the activities of leukotriene A4 hydrolase and cyclooxygenase. In the formula, Ar represents 2-pyridyl, 4-pyridyl, 6-nitro-2-pyridyl, 2-pyrazinyl and relevant hexa-nitrogen heterocyclic ring, phenyl or represents a group in the formula (II), wherein P and Q in the group (II) are respectively at the two positions of 2, 3 and 4 or the benzene ring, and are same or different, and the P and Q respectively represent hydrogen, halogen, amido, nitro, trifluoromethyl, mesyl, mono-methanesulfonamide group, bi-methanesulfonamide group or methyl-sulfamide group.
priorityDate 2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5585492-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419723583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541999
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9993978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753125

Total number of triples: 27.